Treatment outcomes and next-generation sequencing of a rare malignancy - urachal carcinoma: case report and literature review
UrC is a rare malignancy with uncertain pathogenesis. The main symptoms include gross hematuria, abdominal pain, and an abdominal mass. The lack of comprehensive clinical analysis necessitates selecting an optimal therapeutic strategy for each patient. Here, we present a comprehensive review of the clinical manifestations, diagnosis, and treatment of UrC, illustrated with a case successfully managed through surgical intervention and adjuvant chemoradiotherapy. Meanwhile, the analysis of NGS detected two tumor-specific mutated genes: MYC (gene amplification, CN: 59.5) and FLT1 (missense mutation, c.1061G>A (p.R354Q), abundance: 2.1%). These findings may provide insights into tumor growth and guide therapeutic strategies.
Authors
- Chenhui Cao (ORCID: https://orcid.org/0000-0002-8119-0613)
- Xinhao Peng (ORCID: https://orcid.org/0009-0001-4268-395X)
- Dan Shang (ORCID: https://orcid.org/0000-0003-4308-2758)
- Chuan Xu (ORCID: https://orcid.org/0009-0006-0151-8313)
- Senlin Xu
- Linlin Zheng
- Hong Wu
- Jie Chen
- Tian Tan
Institutions
- Army Medical University (CN)
- Third People's Hospital of Chengdu (CN)
- Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN)
- Sichuan Cancer Hospital (CN)
- Southwest Hospital (CN)
- Southwest Jiaotong University (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-04-21
- DOI
- https://doi.org/10.3389/fonc.2026.1744925
- Primary Topic
- Urinary and Genital Oncology Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00